Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Internal and Emergency Medicine
Appendix
Available only for authorised users
Literature
1.
Ostrowski SR, Windelow NA, Ibsen M, Haase N, Perner A, Johansson PI (2013) Consecutive thromboelastography clot strength profiles in patients with severe sepsis and their association with 28-day mortality: a prospective study. J Crit Care 28:317PubMed
2.
Adamik B, Gozdzik W, Jakubczyk D, Welna M, Kubler A (2017) Coagulation abnormalities identified by thromboelastometry in patients with severe sepsis: the relationship to endotoxemia and mortality. Blood Coagul Fibrinol 28(2):163–170
3.
Muller MC, Meijers JCM, Vroom MB, Juffermans NP (2014) Utility of thromboelastography and/or thromboelastometry in adults with sepsis: a systemic review. Crit Care 18:R30CrossRef
4.
Haase N, Ostrowski SR, Wetterslev J et al (2015) Thromboelastography in patients with severe sepsis: a prospective cohort study. Intensive Care Med 41:77–85CrossRef
5.
Dellinger RP, Levy MM, Rhodes A et al (2013) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 39:165–228CrossRef
6.
Iba T et al (2018) The newly proposed sepsis-induced coagulopathy precedes international society on thrombosis and haemostasis overt-disseminated intravascular coagulation and predicts high mortality. J Intensive Care Med 1:885066618773679
7.
Shankar-Hari M, Phillips GS, Levy ML, Sepsis Definition Task Force et al (2016) Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 315:775–787CrossRef
8.
Shankar-Hari M, Harrison DA, Rubenfeld GD, Rowan K (2017) Epidemiology of sepsis and septic shock in critical care units: comparison between sepsis-2 and sepsis-3 populations using a national critical care database. Br J Anaesth 119:626–636CrossRef
9.
Lissaide-Lavigne G et al (2008) Simple coagulation tests improve survival prediction in patients with septic shock. J Thromb Haemost 6:645–653CrossRef
10.
Kollef MH, Eisenberg PR, Shannon W (1998) A rapid assay for the detection of circulating d-dimer is associated with clinical outcomes among critically ill patients. Crit Care Med 26(6):1054–1060CrossRef
11.
Whiting P, Ai M, Westwood M et al (2015) Viscoelastic point-of-care testing to assist with the diagnosis, management and monitoring of haemostasis: a systemic review and cost-effectiveness analysis. Health Technol Assess 19:1–228CrossRef
12.
Serraino GF, Murphy GJ (2017) Routine use of viscoelastic blood tests for diagnosis and treatment of coagulopathic bleeding in cardiac surgery: update systemic review and meta-analysis. Br J Anaesth 118:823–833CrossRef
13.
Davies GR et al (2018) The effect of sepsis and septic shock on the viscoelastic properties of clot quality and mass using rotational thromboelastometry: a prospective observational study. J Crit Care 44:7–11CrossRef
14.
Prakash S et al (2015) Changes in fibrinolysis and severity of organ failure in sepsis: a prospective observational study using point-of-care test-ROTEM. J Crit Care 30(2):264–270CrossRef
15.
Andersen MG, Hvas CL, Tonnesen E, Hvas AM (2014) Thromboelastometry as a supplementary tool for evaluation of hemostasis in severe sepsis and septic shock. Acta Anaesthesiol Scand 58(5):525–533CrossRef
16.
Koch A, Meesters MI, Scheller B, Boer C, Zacharowski K (2013) Systemic endotoxin activity correlates with clot formation: an observational study in patients with early systemic inflammation and sepsis. Crit Care 17:R198CrossRef
17.
Ostrowski SR, Haase N, Muller RB et al (2015) Association between biomarkers of endothelial injury and hypocoagulability in patients with severe sepsis: a prospective study. Crit Care 19:191CrossRef
18.
Tripepi G, Jager KJ, Dekker FW, Zoccali C (2010) Statistical methods for the assessment of prognostic biomarkers (part I): discrimination. Nephrol Dial Transplant 25(5):1399–1401CrossRef
19.
Tripepi G, Jager KJ, Dekker FW, Zoccali C (2010) Statistical methods for the assessment of prognostic biomarkers (part II): calibration and re-classification. Nephrol Dial Transplant 25(5):1402–1405CrossRef
Metadata
Title
The prognostic role of ThromboDynamic Index in patients with severe sepsis
Authors
Annalisa Boscolo
Luca Spiezia
Elena Campello
Elisabetta Maria Consolaro
Carlo Ori
Paolo Simioni
Publication date
01-01-2020
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 1/2020
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-019-02137-w

Other articles of this Issue 1/2020

Internal and Emergency Medicine 1/2020 Go to the issue

IM - ORIGINAL

Thyroid hormones modulate uric acid metabolism in patients with recent onset subclinical hypothyroidism by improving insulin sensitivity

IM - ORIGINAL

Therapeutic action of ketogenic enteral nutrition in obese and overweight patients: a retrospective interventional study

CE - MEDICAL ILLUSTRATION

A giant ovary teratoma with malignant transformation

IM - CASE RECORD

Nephrotic range proteinuria and acute heart failure

IM - REVIEW

Is there a link between venous and arterial thrombosis? A reappraisal

IM - COMMENTARY

Ketogenic enteral nutrition for weight loss: a word of warning

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits